 | • レポートコード：MRC2-11QY04555 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は統合失調症治療のグローバル市場について調査・分析したレポートです。種類別（非定型抗精神病薬、フェノチアジン抗精神病薬、チオキサンテン、その他の抗精神病薬）市場規模、用途別（病院薬局、ドラッグストア、小売薬局、Eコマース）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別統合失調症治療の競争状況、市場シェア ・世界の統合失調症治療市場：種類別市場規模 2015年-2020年（非定型抗精神病薬、フェノチアジン抗精神病薬、チオキサンテン、その他の抗精神病薬） ・世界の統合失調症治療市場：種類別市場規模予測 2021年-2026年（非定型抗精神病薬、フェノチアジン抗精神病薬、チオキサンテン、その他の抗精神病薬） ・世界の統合失調症治療市場：用途別市場規模 2015年-2020年（病院薬局、ドラッグストア、小売薬局、Eコマース） ・世界の統合失調症治療市場：用途別市場規模予測 2021年-2026年（病院薬局、ドラッグストア、小売薬局、Eコマース） ・北米の統合失調症治療市場分析：米国、カナダ ・ヨーロッパの統合失調症治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの統合失調症治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の統合失調症治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの統合失調症治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Johnson and Johnson、Bristol-Myers Squibb、Otsuka、AstraZeneca、Sumitomo Dainippon Pharma、Eli Lilly、Alkermes、Vanda Pharmaceuticals、ALLERGAN、Pfizer ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Schizophrenia is a mental disorder characterized by abnormal behavior and failure to understand reality.
The schizophrenia treatment market is expected to witness a high growth over the forecast period owing to the increasing incidence of schizophrenia.
Market Analysis and Insights: Global Schizophrenia Treatments Market
The global Schizophrenia Treatments market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Schizophrenia Treatments Scope and Market Size
Schizophrenia Treatments market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Schizophrenia Treatments market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Johnson and Johnson
Bristol-Myers Squibb
Otsuka
AstraZeneca
Sumitomo Dainippon Pharma
Eli Lilly
Alkermes
Vanda Pharmaceuticals
ALLERGAN
Pfizer
Market segment by Type, the product can be split into
Atypical Antipsychotics
Phenothiazine Antipsychotics
Thioxanthenes
Miscellaneous Antipsychotic Agents
Market segment by Application, split into
Hospital Pharmacies
Drug Stores
Retail Pharmacies
E-Commerce
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Schizophrenia Treatments Revenue
1.4 Market by Type
1.4.1 Global Schizophrenia Treatments Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Atypical Antipsychotics
1.4.3 Phenothiazine Antipsychotics
1.4.4 Thioxanthenes
1.4.5 Miscellaneous Antipsychotic Agents
1.5 Market by Application
1.5.1 Global Schizophrenia Treatments Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Drug Stores
1.5.4 Retail Pharmacies
1.5.5 E-Commerce
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Schizophrenia Treatments Market Perspective (2015-2026)
2.2 Global Schizophrenia Treatments Growth Trends by Regions
2.2.1 Schizophrenia Treatments Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Schizophrenia Treatments Historic Market Share by Regions (2015-2020)
2.2.3 Schizophrenia Treatments Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Schizophrenia Treatments Market Growth Strategy
2.3.6 Primary Interviews with Key Schizophrenia Treatments Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Schizophrenia Treatments Players by Market Size
3.1.1 Global Top Schizophrenia Treatments Players by Revenue (2015-2020)
3.1.2 Global Schizophrenia Treatments Revenue Market Share by Players (2015-2020)
3.1.3 Global Schizophrenia Treatments Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Schizophrenia Treatments Market Concentration Ratio
3.2.1 Global Schizophrenia Treatments Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Schizophrenia Treatments Revenue in 2019
3.3 Schizophrenia Treatments Key Players Head office and Area Served
3.4 Key Players Schizophrenia Treatments Product Solution and Service
3.5 Date of Enter into Schizophrenia Treatments Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Schizophrenia Treatments Historic Market Size by Type (2015-2020)
4.2 Global Schizophrenia Treatments Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Schizophrenia Treatments Market Size by Application (2015-2020)
5.2 Global Schizophrenia Treatments Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Schizophrenia Treatments Market Size (2015-2020)
6.2 Schizophrenia Treatments Key Players in North America (2019-2020)
6.3 North America Schizophrenia Treatments Market Size by Type (2015-2020)
6.4 North America Schizophrenia Treatments Market Size by Application (2015-2020)
7 Europe
7.1 Europe Schizophrenia Treatments Market Size (2015-2020)
7.2 Schizophrenia Treatments Key Players in Europe (2019-2020)
7.3 Europe Schizophrenia Treatments Market Size by Type (2015-2020)
7.4 Europe Schizophrenia Treatments Market Size by Application (2015-2020)
8 China
8.1 China Schizophrenia Treatments Market Size (2015-2020)
8.2 Schizophrenia Treatments Key Players in China (2019-2020)
8.3 China Schizophrenia Treatments Market Size by Type (2015-2020)
8.4 China Schizophrenia Treatments Market Size by Application (2015-2020)
9 Japan
9.1 Japan Schizophrenia Treatments Market Size (2015-2020)
9.2 Schizophrenia Treatments Key Players in Japan (2019-2020)
9.3 Japan Schizophrenia Treatments Market Size by Type (2015-2020)
9.4 Japan Schizophrenia Treatments Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Schizophrenia Treatments Market Size (2015-2020)
10.2 Schizophrenia Treatments Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Schizophrenia Treatments Market Size by Type (2015-2020)
10.4 Southeast Asia Schizophrenia Treatments Market Size by Application (2015-2020)
11 India
11.1 India Schizophrenia Treatments Market Size (2015-2020)
11.2 Schizophrenia Treatments Key Players in India (2019-2020)
11.3 India Schizophrenia Treatments Market Size by Type (2015-2020)
11.4 India Schizophrenia Treatments Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Schizophrenia Treatments Market Size (2015-2020)
12.2 Schizophrenia Treatments Key Players in Central & South America (2019-2020)
12.3 Central & South America Schizophrenia Treatments Market Size by Type (2015-2020)
12.4 Central & South America Schizophrenia Treatments Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Johnson and Johnson
13.1.1 Johnson and Johnson Company Details
13.1.2 Johnson and Johnson Business Overview
13.1.3 Johnson and Johnson Schizophrenia Treatments Introduction
13.1.4 Johnson and Johnson Revenue in Schizophrenia Treatments Business (2015-2020))
13.1.5 Johnson and Johnson Recent Development
13.2 Bristol-Myers Squibb
13.2.1 Bristol-Myers Squibb Company Details
13.2.2 Bristol-Myers Squibb Business Overview
13.2.3 Bristol-Myers Squibb Schizophrenia Treatments Introduction
13.2.4 Bristol-Myers Squibb Revenue in Schizophrenia Treatments Business (2015-2020)
13.2.5 Bristol-Myers Squibb Recent Development
13.3 Otsuka
13.3.1 Otsuka Company Details
13.3.2 Otsuka Business Overview
13.3.3 Otsuka Schizophrenia Treatments Introduction
13.3.4 Otsuka Revenue in Schizophrenia Treatments Business (2015-2020)
13.3.5 Otsuka Recent Development
13.4 AstraZeneca
13.4.1 AstraZeneca Company Details
13.4.2 AstraZeneca Business Overview
13.4.3 AstraZeneca Schizophrenia Treatments Introduction
13.4.4 AstraZeneca Revenue in Schizophrenia Treatments Business (2015-2020)
13.4.5 AstraZeneca Recent Development
13.5 Sumitomo Dainippon Pharma
13.5.1 Sumitomo Dainippon Pharma Company Details
13.5.2 Sumitomo Dainippon Pharma Business Overview
13.5.3 Sumitomo Dainippon Pharma Schizophrenia Treatments Introduction
13.5.4 Sumitomo Dainippon Pharma Revenue in Schizophrenia Treatments Business (2015-2020)
13.5.5 Sumitomo Dainippon Pharma Recent Development
13.6 Eli Lilly
13.6.1 Eli Lilly Company Details
13.6.2 Eli Lilly Business Overview
13.6.3 Eli Lilly Schizophrenia Treatments Introduction
13.6.4 Eli Lilly Revenue in Schizophrenia Treatments Business (2015-2020)
13.6.5 Eli Lilly Recent Development
13.7 Alkermes
13.7.1 Alkermes Company Details
13.7.2 Alkermes Business Overview
13.7.3 Alkermes Schizophrenia Treatments Introduction
13.7.4 Alkermes Revenue in Schizophrenia Treatments Business (2015-2020)
13.7.5 Alkermes Recent Development
13.8 Vanda Pharmaceuticals
13.8.1 Vanda Pharmaceuticals Company Details
13.8.2 Vanda Pharmaceuticals Business Overview
13.8.3 Vanda Pharmaceuticals Schizophrenia Treatments Introduction
13.8.4 Vanda Pharmaceuticals Revenue in Schizophrenia Treatments Business (2015-2020)
13.8.5 Vanda Pharmaceuticals Recent Development
13.9 ALLERGAN
13.9.1 ALLERGAN Company Details
13.9.2 ALLERGAN Business Overview
13.9.3 ALLERGAN Schizophrenia Treatments Introduction
13.9.4 ALLERGAN Revenue in Schizophrenia Treatments Business (2015-2020)
13.9.5 ALLERGAN Recent Development
13.10 Pfizer
13.10.1 Pfizer Company Details
13.10.2 Pfizer Business Overview
13.10.3 Pfizer Schizophrenia Treatments Introduction
13.10.4 Pfizer Revenue in Schizophrenia Treatments Business (2015-2020)
13.10.5 Pfizer Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Schizophrenia Treatments Key Market Segments
Table 2. Key Players Covered: Ranking by Schizophrenia Treatments Revenue
Table 3. Ranking of Global Top Schizophrenia Treatments Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Schizophrenia Treatments Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Atypical Antipsychotics
Table 6. Key Players of Phenothiazine Antipsychotics
Table 7. Key Players of Thioxanthenes
Table 8. Key Players of Miscellaneous Antipsychotic Agents
Table 9. Global Schizophrenia Treatments Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Schizophrenia Treatments Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Schizophrenia Treatments Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Schizophrenia Treatments Market Share by Regions (2015-2020)
Table 13. Global Schizophrenia Treatments Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Schizophrenia Treatments Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Schizophrenia Treatments Market Growth Strategy
Table 19. Main Points Interviewed from Key Schizophrenia Treatments Players
Table 20. Global Schizophrenia Treatments Revenue by Players (2015-2020) (Million US$)
Table 21. Global Schizophrenia Treatments Market Share by Players (2015-2020)
Table 22. Global Top Schizophrenia Treatments Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Schizophrenia Treatments as of 2019)
Table 23. Global Schizophrenia Treatments by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Schizophrenia Treatments Product Solution and Service
Table 26. Date of Enter into Schizophrenia Treatments Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Schizophrenia Treatments Market Size by Type (2015-2020) (Million US$)
Table 29. Global Schizophrenia Treatments Market Size Share by Type (2015-2020)
Table 30. Global Schizophrenia Treatments Revenue Market Share by Type (2021-2026)
Table 31. Global Schizophrenia Treatments Market Size Share by Application (2015-2020)
Table 32. Global Schizophrenia Treatments Market Size by Application (2015-2020) (Million US$)
Table 33. Global Schizophrenia Treatments Market Size Share by Application (2021-2026)
Table 34. North America Key Players Schizophrenia Treatments Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Schizophrenia Treatments Market Share (2019-2020)
Table 36. North America Schizophrenia Treatments Market Size by Type (2015-2020) (Million US$)
Table 37. North America Schizophrenia Treatments Market Share by Type (2015-2020)
Table 38. North America Schizophrenia Treatments Market Size by Application (2015-2020) (Million US$)
Table 39. North America Schizophrenia Treatments Market Share by Application (2015-2020)
Table 40. Europe Key Players Schizophrenia Treatments Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Schizophrenia Treatments Market Share (2019-2020)
Table 42. Europe Schizophrenia Treatments Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Schizophrenia Treatments Market Share by Type (2015-2020)
Table 44. Europe Schizophrenia Treatments Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Schizophrenia Treatments Market Share by Application (2015-2020)
Table 46. China Key Players Schizophrenia Treatments Revenue (2019-2020) (Million US$)
Table 47. China Key Players Schizophrenia Treatments Market Share (2019-2020)
Table 48. China Schizophrenia Treatments Market Size by Type (2015-2020) (Million US$)
Table 49. China Schizophrenia Treatments Market Share by Type (2015-2020)
Table 50. China Schizophrenia Treatments Market Size by Application (2015-2020) (Million US$)
Table 51. China Schizophrenia Treatments Market Share by Application (2015-2020)
Table 52. Japan Key Players Schizophrenia Treatments Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Schizophrenia Treatments Market Share (2019-2020)
Table 54. Japan Schizophrenia Treatments Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Schizophrenia Treatments Market Share by Type (2015-2020)
Table 56. Japan Schizophrenia Treatments Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Schizophrenia Treatments Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Schizophrenia Treatments Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Schizophrenia Treatments Market Share (2019-2020)
Table 60. Southeast Asia Schizophrenia Treatments Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Schizophrenia Treatments Market Share by Type (2015-2020)
Table 62. Southeast Asia Schizophrenia Treatments Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Schizophrenia Treatments Market Share by Application (2015-2020)
Table 64. India Key Players Schizophrenia Treatments Revenue (2019-2020) (Million US$)
Table 65. India Key Players Schizophrenia Treatments Market Share (2019-2020)
Table 66. India Schizophrenia Treatments Market Size by Type (2015-2020) (Million US$)
Table 67. India Schizophrenia Treatments Market Share by Type (2015-2020)
Table 68. India Schizophrenia Treatments Market Size by Application (2015-2020) (Million US$)
Table 69. India Schizophrenia Treatments Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Schizophrenia Treatments Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Schizophrenia Treatments Market Share (2019-2020)
Table 72. Central & South America Schizophrenia Treatments Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Schizophrenia Treatments Market Share by Type (2015-2020)
Table 74. Central & South America Schizophrenia Treatments Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Schizophrenia Treatments Market Share by Application (2015-2020)
Table 76. Johnson and Johnson Company Details
Table 77. Johnson and Johnson Business Overview
Table 78. Johnson and Johnson Product
Table 79. Johnson and Johnson Revenue in Schizophrenia Treatments Business (2015-2020) (Million US$)
Table 80. Johnson and Johnson Recent Development
Table 81. Bristol-Myers Squibb Company Details
Table 82. Bristol-Myers Squibb Business Overview
Table 83. Bristol-Myers Squibb Product
Table 84. Bristol-Myers Squibb Revenue in Schizophrenia Treatments Business (2015-2020) (Million US$)
Table 85. Bristol-Myers Squibb Recent Development
Table 86. Otsuka Company Details
Table 87. Otsuka Business Overview
Table 88. Otsuka Product
Table 89. Otsuka Revenue in Schizophrenia Treatments Business (2015-2020) (Million US$)
Table 90. Otsuka Recent Development
Table 91. AstraZeneca Company Details
Table 92. AstraZeneca Business Overview
Table 93. AstraZeneca Product
Table 94. AstraZeneca Revenue in Schizophrenia Treatments Business (2015-2020) (Million US$)
Table 95. AstraZeneca Recent Development
Table 96. Sumitomo Dainippon Pharma Company Details
Table 97. Sumitomo Dainippon Pharma Business Overview
Table 98. Sumitomo Dainippon Pharma Product
Table 99. Sumitomo Dainippon Pharma Revenue in Schizophrenia Treatments Business (2015-2020) (Million US$)
Table 100. Sumitomo Dainippon Pharma Recent Development
Table 101. Eli Lilly Company Details
Table 102. Eli Lilly Business Overview
Table 103. Eli Lilly Product
Table 104. Eli Lilly Revenue in Schizophrenia Treatments Business (2015-2020) (Million US$)
Table 105. Eli Lilly Recent Development
Table 106. Alkermes Company Details
Table 107. Alkermes Business Overview
Table 108. Alkermes Product
Table 109. Alkermes Revenue in Schizophrenia Treatments Business (2015-2020) (Million US$)
Table 110. Alkermes Recent Development
Table 111. Vanda Pharmaceuticals Business Overview
Table 112. Vanda Pharmaceuticals Product
Table 113. Vanda Pharmaceuticals Company Details
Table 114. Vanda Pharmaceuticals Revenue in Schizophrenia Treatments Business (2015-2020) (Million US$)
Table 115. Vanda Pharmaceuticals Recent Development
Table 116. ALLERGAN Company Details
Table 117. ALLERGAN Business Overview
Table 118. ALLERGAN Product
Table 119. ALLERGAN Revenue in Schizophrenia Treatments Business (2015-2020) (Million US$)
Table 120. ALLERGAN Recent Development
Table 121. Pfizer Company Details
Table 122. Pfizer Business Overview
Table 123. Pfizer Product
Table 124. Pfizer Revenue in Schizophrenia Treatments Business (2015-2020) (Million US$)
Table 125. Pfizer Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Schizophrenia Treatments Market Share by Type: 2020 VS 2026
Figure 2. Atypical Antipsychotics Features
Figure 3. Phenothiazine Antipsychotics Features
Figure 4. Thioxanthenes Features
Figure 5. Miscellaneous Antipsychotic Agents Features
Figure 6. Global Schizophrenia Treatments Market Share by Application: 2020 VS 2026
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Drug Stores Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. E-Commerce Case Studies
Figure 11. Schizophrenia Treatments Report Years Considered
Figure 12. Global Schizophrenia Treatments Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Schizophrenia Treatments Market Share by Regions: 2020 VS 2026
Figure 14. Global Schizophrenia Treatments Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Schizophrenia Treatments Market Share by Players in 2019
Figure 17. Global Top Schizophrenia Treatments Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Schizophrenia Treatments as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Schizophrenia Treatments Revenue in 2019
Figure 19. North America Schizophrenia Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Schizophrenia Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Schizophrenia Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Schizophrenia Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Schizophrenia Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Schizophrenia Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Schizophrenia Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
統合失調症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Schizophrenia Drugs Market The global Schizophrenia Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Schizophrenia Drugs Scope and Market Size Schizophrenia Drugs market is seg…- 発作治療の世界市場（～2026年） An epileptic seizure is a brief episode of signs or symptoms due to abnormally excessive or synchronous neuronal activity in the brain. Increasing prevalence of neurological disorders is expected to be the dominant factor driving the global seize treatment market over the forecast period. Market Ana…
- 脳腫瘍診断・治療の世界市場（～2026年） With the increasing prevalence of brain cancer, rising aging population, and growing incidences of cancer via chemical exposure, the demand of Diagnosis and treatment of brain tumors is increasing. Market Analysis and Insights: Global Brain Tumor Diagnosis and Treatments Market The global Brain Tumo…
- 帯状疱疹治療の世界市場（～2026年） Shingles is a viral disease characterized by a painful skin rash with blisters in a localized area. The shingles treatment market is expected to witness a high growth over the forecast period owing to the increasing prevalence of shingles. Market Analysis and Insights: Global Shingles Treatments Mar…
- 薬物アレルギー治療/治療薬の世界市場（～2026年） Market Analysis and Insights: Global Drug Allergy Treatments and Drugs Market The global Drug Allergy Treatments and Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Drug Allergy Treatments and Drugs Scope and Mar…